Frailty in Focus
Clinical Journal of the American Society of Nephrology · 2026-05 · 21 (5) · 775-790
DOI: 10.2215/cjn.0000000998 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Journal of the American Society of Nephrology, online erschienen am 21.01.2026. Verfasst von Devika Nair und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, NINR NIH HHS.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Key Points The clinical frailty scale has the strongest psychometric validity in kidney disease apart from the physical frailty phenotype. Existing frailty instruments have strong predictive validity for mortality and hospitalizations across kidney disease populations. Future work should test validity in younger adults, psychosocial and physiologic domains, and use of frailty instruments as screeners.
Background
Frailty is a multisystem syndrome of decreased physiologic reserve with high prevalence, early incidence, and prognostic significance in kidney disease. Apart from the physical frailty phenotype (PFP), less is known regarding psychometric properties of other instruments. We critically appraise the validity and reliability of frailty instruments across the kidney disease continuum, acknowledge limitations, and highlight knowledge gaps.
Methods
Following Preferred Reporting Items for Scoping Reviews guidelines, we searched PubMed, EMBASE, Cochrane, Cumulated Index in Nursing and Allied Health Literature, Web of Science, ClinicalTrials.gov, and PsycInfo from website inception through September 2024. Eligible studies applied a validated frailty instrument apart from the PFP to a kidney disease population.
Results
We identified 136 articles after screening 4048 initial results. The most commonly cited instruments were the clinical frailty scale (CFS; N =56); Fatigue, Resistance, Ambulation, Illnesses, and Loss of Weight Scale ( N =30); and Edmonton frail scale ( N =16). Most studies included adults receiving hemodialysis ( N =85) and with CKD ( N =39). Median age ranges were 53–83 years. Most frailty instruments demonstrated predictive validity for mortality and hospitalizations. Concurrent validity was most frequently demonstrated between frailty and older age, female sex, greater comorbidities, and lower albumin. Seven studies reported reliability. While some instruments were feasible (CFS, Fatigue, Resistance, Ambulation, Illnesses, and Loss of Weight scale), their measurement could result in higher frailty prevalence compared with the PFP. Existing instruments do not capture the full spectrum of psychosocial and physiologic domains of frailty.
Conclusions
The CFS demonstrates the strongest validity, apart from the PFP, although its use may result in higher measured frailty prevalence. Further research should test the feasibility of screening for frailty in clinical practice; the psychometric properties ( i.e ., responsiveness) of frailty instruments in younger adults, those with AKI, kidney transplant recipients, and those receiving conservative kidney management; and whether adding psychosocial and/or physiologic markers improves frailty measurement validity. Addressing these gaps will facilitate wider frailty measurement in kidney disease research and aid adoption into practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee.
- Vanderbilt Center for Health Services Research, Vanderbilt University Medical Center, Nashville, Tennessee.
- Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee.
- Veteran Wellbeing through Innovation Systems Science and Experience in Learning Health Systems (VETWISE-LHS) Center of Innovation, Nashville, Tennessee.
- Department of Surgery, New York University Grossman School of Medicine and Langone Health, New York, New York.
- NYU Health Sciences Library, NYU Grossman School of Medicine, NYU Langone Health, New York, New York.
ORCID-Profile: Ilana Mittleman, Juliana Magro, Benjamin Catanese, Mary F Hannan, Melissa D Hladek, Jingyao Hong, Nan-Su Huang, Karthik K Tennankore, Dawn F Wolfgram, Rasheeda K Hall
Förderung
- NIDDK NIH HHS
- NIH HHS
- NINR NIH HHS
- Center for Innovations in Quality, Effectiveness and Safety
- NIA NIH HHS
- National Institute on Aging
- National Institutes of Health
Zitieren
APA
Nair, D., Mittleman, I., Magro, J., Catanese, B., Hannan, M. F., Hladek, M. D., Hong, J., Huang, N. S., Taylor, M. H., Tennankore, K. K., Wolfgram, D. F., Hall, R. K., McAdams-DeMarco, M., & Kidney Disease Aging Research Collaborative (2026). Frailty in Focus. Clinical Journal of the American Society of Nephrology, 21(5), 775-790. https://doi.org/10.2215/cjn.0000000998
Vancouver
Nair D, Mittleman I, Magro J, Catanese B, Hannan MF, Hladek MD, et al. Frailty in Focus. Clinical Journal of the American Society of Nephrology. 2026;21(5):775-790. doi:10.2215/cjn.0000000998
BibTeX
@article{Nair2026,
author = {Nair, Devika and Mittleman, Ilana and Magro, Juliana and Catanese, Benjamin and Hannan, Mary F and Hladek, Melissa D and Hong, Jingyao and Huang, Nan-Su and Taylor, Matthew H and Tennankore, Karthik K and Wolfgram, Dawn F and Hall, Rasheeda K and McAdams-DeMarco, Mara and Kidney Disease Aging Research Collaborative, Kidney Disease Aging Research Collaborative},
title = {Frailty in Focus},
journal = {Clinical Journal of the American Society of Nephrology},
year = {2026},
volume = {21},
number = {5},
pages = {775--790},
doi = {10.2215/cjn.0000000998}
}
EUVIMED